Innovate Biopharmaceuticals, Inc. (INNT): Price and Financial Metrics

Innovate Biopharmaceuticals, Inc. (INNT): $0.56

0.14 (-20.23%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add INNT to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked


in industry

INNT Price/Volume Stats

Current price $0.56 52-week high $1.67
Prev. close $0.70 52-week low $0.37
Day low $0.55 Volume 1,547,700
Day high $0.72 Avg. volume 525,982
50-day MA $0.52 Dividend yield N/A
200-day MA $0.77 Market Cap 23.14M

INNT Stock Price Chart Interactive Chart >


Innovate Biopharmaceuticals, Inc. (INNT) Company Bio


Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing autoimmune and inflammation therapeutics. Its late-stage clinical pipeline focuses on addressing unmet needs in diseases, such as celiac disease, inflammatory bowel disease (IBD), and nonalcoholic steatohepatitis (NASH). The company's lead drug candidate, larazotide acetate (INN-202), has successfully met its primary endpoint in a Phase 2b efficacy clinical trial for celiac disease. It is also developing INN-108, which is entering into Phase 2 clinical trials for the treatment of mild to moderate ulcerative colitis. In addition, the company owns the global rights to INN-329, a proprietary formulation of secretin, a peptide hormone used to enhance visualization in magnetic resonance cholangiopancreatography procedures. Innovate Biopharmaceuticals, Inc. was founded in 2012 and is based in Raleigh, North Carolina.


INNT Latest News Stream


Event/Time News Detail
Loading, please wait...

INNT Latest Social Stream


Loading social stream, please wait...

View Full INNT Social Stream

INNT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year -25.33%
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 0.00%
2019 -75.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!